Why Editas Medicine Stock Is Tumbling Today
Shares of Editas Medicine (NASDAQ: EDIT) were tumbling 16.3% as of 11:28 a.m. EST on Monday. The update that likely most rattled investors was that Editas' chief scientific officer, Charles Albright, is leaving the company to pursue another opportunity.